BioSpace News Archive

Real-world effectiveness data on Oxbryta® (voxelotor) in the treatment of sickle cell disease featured as oral presentation

Protalix BioTherapeutics, Inc. announced that on Wednesday, October 28, 2020, at 10:00 a.m. EDT, it will participate in the Virtual KOL Roundtable, covering both the Company and pegunigalsidase alfa, or PRX–102, the Company’s lead drug candidate for the treatment of Fabry Disease.

The escalating need for an advanced ultrasonic testing method in the healthcare sector may help the global phased array ultrasonic transducer market gain immense growth prospects across the forecast period of 2019-2029.

According to Transparency Market Research’s latest report on the global oral contraceptive pills market for the historical period 2017–2018 and forecast period 2019–2027, high incidence of unintended pregnancies, awareness programs by governments and NGOs, increase in maternal age and late pregnancies are projected to drive the global oral contraceptive pills market during the forecast period

Biomarkers in oncology along with the assortment of new technologies to identify them are vital in the management of various cancer types.

Acquisition fuels Bayer’s cell and gene therapy platform with potential to bring urgently needed treatments to patients across multiple disease areas with high unmet need

REX-001 is an autologous cell-based product intended to treat critical limb-threatening ischaemia in diabetic patients

Boundless Bio’s Spyglass™ platform contains essential toolkit for characterizing ecDNA in cancer cells and its responses to therapeutic pressures

TransEnterix, Inc. announced that it plans to release third quarter financial and operating results after the market closes on Thursday, November 5, 2020.